Clinical Trial Update: Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

View source ↗

Summary

This clinical trial update describes a pharmacogenomic study of the anti-VEGF drug Conbercept for macular neovascular diseases, including age-related macular de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Pathological Myopia
• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Xun Xu | Conditions: Age-Related Macular Degeneration, Polypoidal Choroidal Vasculopathy | Status: UNKNOWN